facebook twitter linkedin

This material was prepared by a third party towards Selvita S.A. with its registered office in Kraków (hereunder: “Selvita”). Within the scope which was not authorized by Selvita’s management board, the description of factual circumstances regarding the activities of Selvita, embodied in this material presents merely opinion of the third party, in particular with respect to presented opinions, predictions, appraisals and forecasts of the financial data and future activity of Selvita and its results.

Therefore, Selvita does not warrant consistency of this material with the actual and legal situation. Neither Selvita, members of its corporate bodies, employees nor its consultants shall bear any liability for validity of opinions, predictions, appraisals, forecasts and any other date embodied in this material as well as for consequences of actions of any reader made on a basis of this material, in particular for the investment decisions or any losses resulting from use of this material.

Readers of this material shall make its own assessment, whether opinions or forecasts embodied therein are credible and adequate, in particular taking into account their investment strategy and actual and legal situation. In particular they should consult it with their independent financial and investment advisors. None of the information presented in this material shall constitute investment, legal, accounting or tax advice or a statement that any investment strategy is accurate or adequate, considering the circumstances of the reader.

Furthermore date presented in this material shall not constitute an offer to sell or purchase any financial instruments nor an invite the make such offer. It shall not be also not deemed as a recommendation for investment in any financial instrument nor an advertisement of such instruments.



DISAGREE AGREE
Place: London, 19th-20th January 2011, Radisson Blu Portman Hotel
 
With businesses under more pressure to innovate than ever before, regardless of the cost-cutting climate, now is the time to find ways to 
enhance the product pipeline and drive new drugs to market and emerge from the economic crisis with the competitive edge.
BioBusiness 2011 event creates the opportunity to network with the leading big and mid-tier pharmaceutical companies, as well as the most innovative biotech firms across the globe. 
 
This conference provides with two days of networking, case studies, roundtable discussions and investment challenges, ensuring you make the most of your experience at the forum.
 
To contact Selvita's delegate at this conference please email at: selvita@selvita.com
 
More information about the conference